Acute myelogenous leukemia: advances and limitations of treatment. [electronic resource]
Producer: 20020717Description: 257-63 p. digitalISSN:- 1079-2104
- Adult
- Aminoglycosides
- Anthracyclines -- therapeutic use
- Anti-Bacterial Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antigens, CD -- metabolism
- Antigens, Differentiation, Myelomonocytic -- metabolism
- Antimetabolites, Antineoplastic -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Case-Control Studies
- Cytarabine -- therapeutic use
- Fatal Outcome
- Gemtuzumab
- Gingiva -- pathology
- Hematopoietic Stem Cell Transplantation
- Humans
- Imatinib Mesylate
- Immunosuppressive Agents -- therapeutic use
- Immunotoxins -- therapeutic use
- Leukemia, Myeloid, Acute -- therapy
- Leukemic Infiltration
- Male
- Piperazines -- therapeutic use
- Pyrimidines -- therapeutic use
- Remission Induction
- Sialic Acid Binding Ig-like Lectin 3
No physical items for this record
Publication Type: Case Reports; Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.